Expert Opinion on Therapeutic Patents, Volume 17, Issue 11 (2007)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Therapeutic Patents, Volume 17, Issue 11 (2007)

See all volumes and issues
Vol 34, 2024 Vol 33, 2023 Vol 32, 2022 Vol 31, 2021 Vol 30, 2020 Vol 29, 2019 Vol 28, 2018 Vol 27, 2017 Vol 26, 2016 Vol 25, 2015 Vol 24, 2014 Vol 23, 2013 Vol 22, 2012 Vol 21, 2011 Vol 20, 2010 Vol 19, 2009 Vol 18, 2008 Volume 17, 2007 Vol 16, 2006 Vol 15, 2005 Vol 14, 2004 Vol 13, 2003 Vol 12, 2002 Vol 11, 2001 Vol 10, 2000 Vol 9, 1999 Vol 8, 1998 Vol 7, 1997 Vol 6, 1996 Vol 5, 1995 Vol 4, 1994 Vol 3, 1993 Vol 2, 1992 Vol 1, 1991
Download citations Download PDFs Download issue

Editorial

Article
Therapies for adrenal insufficiency
Massimiliano Andrioli MD, Francesca Pecori Giraldi MD, Martina De Martin MD & Francesco Cavagnini
Pages: 1323-1329
Published online: 09 Nov 2007
AbstractforTherapies for adrenal insufficiency | Full Text | References | PDF (136.7 KB)
  • 55 Views
  • 3 CrossRef citations
  • 0Altmetric

Review

Article
Antisense and small-molecule modulation of diacylglycerol acyltransferase
Brian K Hubbard, Istvan Enyedy, Thomas A Gilmore & Michael H Serrano-Wu
Pages: 1331-1339
Published online: 09 Nov 2007
AbstractforAntisense and small-molecule modulation of diacylglycerol acyltransferase | Full Text | References | PDF (283.3 KB)
  • 87 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Bacteriophages and phage-derived products as antibacterial therapeutics
Jason J Gill, Taras Hollyer & Parviz M Sabour
Pages: 1341-1350
Published online: 09 Nov 2007
AbstractforBacteriophages and phage-derived products as antibacterial therapeutics | Full Text | References | PDF (153.4 KB)
  • 150 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
A new era in the treatment of age-related macular degeneration: from Factor X to antiangiogenesis
Maria-Andreea Gamulescu MD & Horst Helbig MD
Pages: 1351-1363
Published online: 09 Nov 2007
AbstractforA new era in the treatment of age-related macular degeneration: from Factor X to antiangiogenesis | Full Text | References | PDF (161.2 KB)
  • 35 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
The quest for the treatment of cognitive impairment: α7 nicotinic and α5 GABAA receptor modulators
Maria Novella Romanelli & Fulvio Gualtieri
Pages: 1365-1377
Published online: 09 Nov 2007
AbstractforThe quest for the treatment of cognitive impairment: α7 nicotinic and α5 GABAA receptor modulators | Full Text | References | PDF (272 KB)
  • 60 Views
  • 5 CrossRef citations
  • 0Altmetric

Annotated Patent Selections

Article
Annotated Patent Selections
Pages: 1379-1392
Published online: 09 Nov 2007
First Page PreviewforAnnotated Patent Selections | Full Text | PDF (143.7 KB)
  • 27 Views
  • 0 CrossRef citations
  • 0Altmetric

Patent Evaluation

Article
Carbonic anhydrase IX inhibitors: fluorescent sulfonamides as therapeutic and diagnostic agents
Supuran CT; Scozzafava A: WO2006137092
Jean-Yves Winum PhD
Pages: 1393-1396
Published online: 09 Nov 2007
AbstractforCarbonic anhydrase IX inhibitors: fluorescent sulfonamides as therapeutic and diagnostic agents | Full Text | References | PDF (128.3 KB)
  • 39 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
New nitric oxide-releasing polymers for implantable devices
Medtronic Vascular, Inc.: WO2007030266
Roberto Scatena MD
Pages: 1397-1400
Published online: 09 Nov 2007
AbstractforNew nitric oxide-releasing polymers for implantable devices | Full Text | References | PDF (110.4 KB)
  • 61 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Combinations of a long-acting β2 agonist; is it BI-1744-CL?
Boehringer Ingelheim: WO2007042467 and WO2007042468
Peter Norman
Pages: 1401-1404
Published online: 09 Nov 2007
AbstractforCombinations of a long-acting β2 agonist; is it BI-1744-CL? | Full Text | References | PDF (126.3 KB)
  • 46 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Anticancer drugs: where are we now?
Giuseppina De Simone et al.
Editorial | Published online: 15 May 2024
Free Access
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors – a review of patent literature from 2019-June 2023
Esther C. Y. Lee et al.
Review Article | Published online: 14 May 2024
Recent trends and challenges to overcome Pseudomonas aeruginosa infections
Alessandra Ammazzalorso et al.
Review Article | Published online: 3 May 2024
An insight into the last 5-year patents on porphyromonas gingivalis and streptococcus mutans, the pivotal pathogens in the oral cavity
Bianca Laura Bernardoni et al.
Review Article | Published online: 29 Apr 2024
View all latest articles